Pulse Biosciences CellFX System

· Pulse Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pulse Biosciences CellFX System, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System [NA]